Allergy and Immunology News of the Day

Health News of the Day is a daily summary made from the selected links I post on Twitter. It is in a bullet points format with links to the original sources which include 350 RSS feeds that produce about 2,500 items per day.

Prophylactic antipyretics at the time of vaccination may reduce antibody responses to several vaccine antigens http://bit.ly/BR3XR

FDA requests more information from Novartis prior to QAB149 (indacaterol) approval http://bit.ly/3w6bpH -- QAB149, indacaterol, the first once-daily LABA is already approved in Europe. Noavrtis to address FDA's dosing concerns http://bit.ly/3w6bpH

Omalizumab Highly Effective for Refractory Urticaria in Randomized Trial http://bit.ly/2KCtEX

ICS fluticasone decreases inflammation and FEV1 decline in COPD. Adding LABAs does not enhance these effects. http://bit.ly/1uK7Q4

How does a tick bite trigger a sudden allergy to meat? WaPost http://bit.ly/15CqtN

Belimumab (Benlysta) is a human monoclonal antibody that could become the first new drug for SLE in five decades http://bit.ly/4CSdAq -- Belimumab inhibits B-Lymphocyte stimulator (BLyS), also known as B cell activation factor of the TNF family (BAFF) http://bit.ly/C9aEz

It can happen: Methylprednisolone-induced anaphylaxis http://bit.ly/1Trki9

Eosinophilic panniculitis: a new form of local reaction with specific immunotherapy http://bit.ly/4ev0tC

Th17 immunity may be also involved in the pathogenesis of allergic asthma http://bit.ly/3fIX2s

Medical news tweets are not research articles - they are 140-character messages - please always go to the original source, links, etc. Tweets and links do not represent endorsement, approval or support. Image source: OpenClipArt.org, public domain.

Follow me on Twitter:

No comments:

Post a Comment

Blog Widget by LinkWithin